COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,164 Articles (22,703 medRxiv, 8,461 bioRxiv)

Most recent first Previous |  Page 2626: Articles 26251-26260  | Next

Households at Higher Risk of Losing at Least One Individual in India: if COVID-19 is a new normal
Singh, R. R., Sharma, P., Maurya, P.
10.1101/2020.06.08.20125203 — Posted: 2020-06-09
Changing patterns of mortality during the COVID-19 pandemic: population-based modelling to understand palliative care implications
Bone, A. E., Finucane, A. M., Leniz, J., Higginson, I. J., Sleeman, K. E.
10.1101/2020.06.07.20124693 — Posted: 2020-06-09
D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly
Cavallo, L., Oliva, R.
10.1101/2020.06.08.140152 — Posted: 2020-06-09
Adverse Outcomes and Mortality in Users of Non-Steroidal Anti-Inflammatory Drugs tested positive for SARS-CoV-2: A Danish Nationwide Cohort Study
Lund, L. C., Kristensen, K. B., Reilev, M., Christensen, S., Thomsen, R. W., Christiansen, C. F., Stoevring, H., Johansen, N. B., Brun, N., Hallas, J., Pottegaard, A.
10.1101/2020.06.08.20115683 — Posted: 2020-06-09
Scrutinizing the heterogeneous spreading of COVID-19 outbreak in Brazilian territory
Da Silva, R. M., Mendes, C. F. d. O., Manchein, C.
10.1101/2020.06.05.20123604 — Posted: 2020-06-09
Protection after Quarantine: Insights from a Q-SEIR Model with Nonlinear Incidence Rates Applied to COVID-19
Minoza, J. M. A., Sevilleja, J. E. A. D., de Castro, R., Caoili, S. E., Bongolan, V. P.
10.1101/2020.06.06.20124388 — Posted: 2020-06-09
Hydroxychloroquine inhibits trained immunity - implications for COVID-19
Rother, N., Yanginlar, C., Lindeboom, R. G. H., Bekkering, S., van Leent, M. M. T., Buijsers, B., Jonkman, I., de Graaf, M., Baltissen, M., Lamers, L. A., Riksen, N. P., Fayad, Z. A., Mulder, W. J. M., Hilbrands, L. B., Joosten, L. A. B., Netea, M. G., Vermeulen, M., van der Vlag, J., Duivenvoorden, R.
10.1101/2020.06.08.20122143 — Posted: 2020-06-09 Discussion: Onsite
No Evidence for Reduced Hospital Admissions or Increased Deaths from Stroke or Heart Attack During COVID-19
Reeves, K., Watson, S. I., Pankhurst, T., Khunti, K., Gallier, S., Skrybant, M., Chilton, P. J., Lilford, R. J.
10.1101/2020.06.08.20119636 — Posted: 2020-06-09
Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity
Lynch, K. L., Whitman, J. D., Lacanienta, N. P., Beckerdite, E. W., Kastner, S. A., Shy, B. R., Goldgof, G. M., Levine, A. G., Bapat, S. P., Stramer, S. L., Esensten, J. H., Hightower, A. W., Bern, C., Wu, A. H.
10.1101/2020.06.03.20121525 — Posted: 2020-06-09
SARS-CoV-2 placental infection and inflammation leading to fetal distress and neonatal multi-organ failure in an asymptomatic woman
Schoenmakers, S., Snijder, P., Verdijk, R., Kuiken, T., Kamphuis, S., Koopman, L., Krasemann, T., Rousian, M., Broekhuizen, M., Steegers, E., Koopmans, M., Fraaij, P., Reiss, I.
10.1101/2020.06.08.20110437 — Posted: 2020-06-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).